£109.49

Academic Press RAS: Past, Present, and Future (Volume 153) (Advances in Cancer Research, Volume 153)

Price data last checked 13 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 2 months ago.

£109 today · all-time low £109 (May 2026) · usually £110

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 78 days • 78 data points (No recent data available)

Historical
Generating forecast...
£111.99 £108.69 £109.41 £110.13 £110.85 £111.57 £112.29 08 April 2026 27 April 2026 16 May 2026 04 June 2026 24 June 2026

Price Distribution

Price distribution over 78 days • 4 price levels

Days at Price
Current Price
27 days · current 18 days · current 8 days 25 days 0 7 14 20 27 £109 £110 £111 £112 Days at Price

Price Analysis

Most common price: £109 (27 days, 34.6%)

Price range: £109 - £112

Price levels: 4 different prices over 78 days

Description

Advances in Cancer Research, volume 153 provides a timely review of the biology, biochemistry, and current approaches to therapeutically target the RAS oncoprotein, the most frequently mutated oncogene family in human cancers. 2021 saw the approval of the first direct RAS inhibitor (sotorasib) for use in treating non-small cell lung cancers harboring KRAS(G12C) mutations. The successful approval and use of this drug highlights that the once “undruggable RAS is indeed pharmacologically tractable. This volume provides an overview of efforts to develop additional approaches to therapeutically target oncogenic RAS. In addition, the reader will find excellent reviews on the history and research efforts to understand the biochemistry and oncogenic activity of RAS in human cancers. Overview of the history and development of efforts to pharmacologically inhibit RAS. Discussion of the biochemistry and biology of different RAS mutant proteins and how this might be effectively leveraged in the development of anti-RAS therapies. Up-to-date reviews of the cutting-edge approaches to develop new anti-RAS pharmacologics.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
08 February 2022
Listed Since
15 July 2021

Barcode

No barcode data available

Similar Products You Might Like

Targeted Therapies in Oncology
95% match

Targeted Therapies in Oncology

CRC Press

£62.60 02 Jul 2026
Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)
95% match

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Humana

£88.19 03 Jul 2026
Lipid-Based Nanocarriers for Drug Delivery and Diagnosis (Micro and Nano Technologies)
95% match

Lipid-Based Nanocarriers for Drug Delivery and Diagnosis (Micro and Nano Technologies)

William Andrew

£120.49 18 Apr 2026
Advancing Development of Synthetic Gene Regulators: With the Power of High-Throughput Sequencing in Chemical Biology (Springer Theses)
95% match

Advancing Development of Synthetic Gene Regulators: With the Power of High-Throughput Sequencing in Chemical Biology (Springer Theses)

Springer

£75.84 10 Mar 2026
Hsp90 in Cancer: Beyond the Usual Suspects (Volume 129) (Advances in Cancer Research, Volume 129)
94% match

Hsp90 in Cancer: Beyond the Usual Suspects (Volume 129) (Advances in Cancer Research, Volume 129)

Academic Press

£110.59 10 Mar 2026
Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)
94% match

Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)

Academic Press

£117.19 06 Mar 2026
Epigenetics of Cancer Prevention (Volume 8) (Translational Epigenetics, Volume 8)
94% match

Epigenetics of Cancer Prevention (Volume 8) (Translational Epigenetics, Volume 8)

Academic Press

£94.99 08 Apr 2026
Cellular and Molecular Biology of Metals
94% match

Cellular and Molecular Biology of Metals

CRC Press

£150.70 27 Jun 2026
CRC Press - Chemistry and Pharmacology of Anticancer Drugs
94% match

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

CRC Press

£133.99 15 Apr 2026
Chemistry and Pharmacology of Anticancer Drugs
94% match

Chemistry and Pharmacology of Anticancer Drugs

CRC Press

£192.76 17 Apr 2026
Cancer Cell Signaling: Targeting Signaling Pathways Toward Therapeutic Approaches to Cancer
94% match

Cancer Cell Signaling: Targeting Signaling Pathways Toward Therapeutic Approaches to Cancer

CRC Press

£77.06 04 Jul 2026
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
94% match

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Springer

£165.95 09 Apr 2026
Conquering RAS: From Biology to Cancer Therapy
94% match

Conquering RAS: From Biology to Cancer Therapy

Academic Press

£95.99 09 Mar 2026
Academic Press - Unraveling the Complexities of Metastasis
94% match

Academic Press - Unraveling the Complexities of Metastasis

Academic Press

£116.98 19 Apr 2026
Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)
94% match

Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)

Humana

£74.07 07 Mar 2026
Animal Models in Cancer Drug Discovery
94% match

Animal Models in Cancer Drug Discovery

Academic Press

£117.49 05 Apr 2026
Small Molecules for Cancer Treatment
94% match

Small Molecules for Cancer Treatment

Springer

£160.65 25 Jun 2026
Sirtuin Biology in Cancer and Metabolic Disease: Cellular Pathways for Clinical Discovery
94% match

Sirtuin Biology in Cancer and Metabolic Disease: Cellular Pathways for Clinical Discovery

Academic Press

£76.43 01 Jul 2026
Structure–Activity Relationships for Development of Neurokinin-3 Receptor Antagonists: Reducing Environmental Impact (Springer Theses)
94% match

Structure–Activity Relationships for Development of Neurokinin-3 Receptor Antagonists: Reducing Environmental Impact (Springer Theses)

Springer

£73.85 07 Jul 2026
Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)
94% match

Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)

Humana

£183.54 21 Jun 2026
Biophotonics, Tryptophan and Disease
94% match

Biophotonics, Tryptophan and Disease

Academic Press

£102.79 06 Jul 2026
Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)
94% match

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Academic Press

£111.19 10 Mar 2026
Molecular Biology of SARS-CoV-2: Opportunities for Antivirus Drug Development
94% match

Molecular Biology of SARS-CoV-2: Opportunities for Antivirus Drug Development

Lippincott Williams & Wilkins

£133.33 20 Jun 2026
Drug Resistance in Cancer Cells
94% match

Drug Resistance in Cancer Cells

Springer

£107.73 08 Apr 2026